ELRIG Announces Drug Discovery 2013 Preliminary Programme and Call for Posters
Product News May 02, 2013
The 2013 programme will contain scientific presentations, an exhibition area with over 100 vendor booths, a networking event, poster sessions, Innovation Zone, Media Area and Careers Zone. Registration for the event is free, and delegates can register online at www.elrig.org.
The scientific sessions will feature presentations from leading scientists, including the show keynote address from Dr Ruth McKernan, CSO of Pfizer’s Neusentis Unit, on ‘Practical applications of stem cell-derived cells within drug discovery’. The eight scientific sessions are:
• Target & Biomarker Identification & Validation
• Advanced Cell Technologies
• In vitro DMPK & Safety Screening
• Macromolecules as Therapeutics
• Innovations in Assay Development & Screening
• Science Led sample Management – putting the horse before the cart
• Oncology Drug Targets – where next?
• Macromolecules as Tools for Discovery & Target Validation
ELRIG is calling for poster abstract submissions, which should be sent to firstname.lastname@example.org. This year a subset of poster abstracts will be selected for 10 minute oral presentations, to be given within the main symposia sessions. Delegates will be given the chance to vote for the best poster, with a prize for the poster receiving the highest number of votes.
In collaboration with SLAS (Society for Laboratory Automation and Screening), students, graduates and post-docs are again invited to submit a poster for entry into the Young Scientist Award, the winner of which will receive a $500 cash prize, as well as an expenses-paid trip to present and participate in the Student Poster Competition at SLAS2014, 18-22 January 2014 in San Diego, CA.
Following on from the success of last year’s Dragons Den,this will also be a feature of the 2013 event. Companies are encouraged to come forward to pitch to the panel of ‘Dragons’. To find out more please contact Adrian Kinkaid: email@example.com.